95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.60%
Positive revenue growth while FSM is negative. John Neff might see a notable competitive edge here.
-0.21%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
1.18%
Positive EBIT growth while FSM is negative. John Neff might see a substantial edge in operational management.
1.18%
Positive operating income growth while FSM is negative. John Neff might view this as a competitive edge in operations.
7.19%
Positive net income growth while FSM is negative. John Neff might see a big relative performance advantage.
7.89%
Positive EPS growth while FSM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
7.89%
Positive diluted EPS growth while FSM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.06%
Slight or no buybacks while FSM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.02%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
199.89%
Dividend growth of 199.89% while FSM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-2.13%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
453.95%
FCF growth above 1.5x FSM's 55.77%. David Dodd would verify if the firm’s strategic investments yield superior returns.
571.98%
10Y CAGR of 571.98% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
174.59%
5Y CAGR of 174.59% while FSM is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
295.52%
3Y revenue/share CAGR under 50% of FSM's 6023.95%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
9273.18%
10Y OCF/share CAGR above 1.5x FSM's 2140.64%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
242.80%
OCF/share CAGR of 242.80% while FSM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
489.03%
3Y OCF/share CAGR above 1.5x FSM's 21.18%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
13730.08%
Positive 10Y CAGR while FSM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
280.54%
Net income/share CAGR of 280.54% while FSM is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
321.94%
3Y net income/share CAGR above 1.5x FSM's 38.36%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
2138.64%
10Y equity/share CAGR above 1.5x FSM's 924.06%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
158.46%
Equity/share CAGR of 158.46% while FSM is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
128.51%
3Y equity/share CAGR 1.25-1.5x FSM's 103.92%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-66.87%
Firm’s AR is declining while FSM shows 6.01%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
4.04%
Asset growth above 1.5x FSM's 0.65%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.81%
Under 50% of FSM's 16.23%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-8.33%
We’re deleveraging while FSM stands at 11.30%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-7.24%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.